• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于美国医学物理学家协会(AAPM)TG-218报告设定颅脊髓照射容积调强弧形治疗患者特异性质量保证的公差和行动限值

Setting the Tolerance and Action Limit for Patient-specific Quality Assurance of Craniospinal Irradiation Volumetric Modulated Arc Therapy: Based on AAPM TG-218 Report.

作者信息

Raj Sathiya, Saminathan Sathiyan, Prakasam Kiruthika

机构信息

Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India.

出版信息

J Med Phys. 2025 Jan-Mar;50(1):155-159. doi: 10.4103/jmp.jmp_156_24. Epub 2025 Mar 7.

DOI:10.4103/jmp.jmp_156_24
PMID:40256190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12005663/
Abstract

PURPOSE

The purpose of this study was to investigate the tolerance limits (TL) and action limits (AL) in gamma passing rate for craniospinal irradiation volumetric modulated arc therapy (VMAT) treatment plans.

MATERIALS AND METHODS

Twenty-eight patients were planned using the VMAT technique; plans were delivered on an Elekta Versa HD. The delivered fluence was recorded by PTW 2D array, and the gamma passing rate (%GP) was analyzed using PTW VeriSoft. The universal TL and AL from TG 218 were applied to analyze the %GP for each plan. As per AAPM TG 218, a statistical process control of %GP was performed to set the TL and AL.

RESULTS

The average %GP for the brain, upper spine, and lower spine was 98.4%, 98.8%, and 98.4%, respectively. The TL and AL for the brain, upper spine, and lower spine were TL: 95.1%, 95.1% and 94.8%, and AL: 89.7%, 89.3%, and 86.7%, respectively. The analysis of variance test showed that the value in %GP among the brain, upper spine, and lower spine was >0.1679. The %GP rate between the sites was not statistically significant.

CONCLUSION

AAPM TG 218 guidelines are more suitable for establishing TL and AL for craniospinal irradiation (CSI) VMAT plans. This study suggests that a single value of TL and AL for CSI plans, rather than site-specific values, could be suitable for monitoring CSI patient-specific quality assurance trends and the same can be utilized.

摘要

目的

本研究旨在探讨颅脊髓照射容积调强弧形治疗(VMAT)计划中伽马通过率的耐受限度(TL)和行动限度(AL)。

材料与方法

采用VMAT技术为28例患者制定计划;计划在Elekta Versa HD设备上实施。通过PTW二维阵列记录输出的注量,并使用PTW VeriSoft分析伽马通过率(%GP)。应用来自TG 218的通用TL和AL来分析每个计划的%GP。根据AAPM TG 218,对%GP进行统计过程控制以设定TL和AL。

结果

脑、上脊柱和下脊柱的平均%GP分别为98.4%、98.8%和98.4%。脑、上脊柱和下脊柱的TL分别为95.1%、95.1%和94.8%,AL分别为89.7%、89.3%和86.7%。方差分析表明,脑、上脊柱和下脊柱之间%GP的 值>0.1679。各部位之间的%GP率无统计学差异。

结论

AAPM TG 218指南更适合为颅脊髓照射(CSI)VMAT计划建立TL和AL。本研究表明,CSI计划采用单一的TL和AL值,而非特定部位的值,可能适用于监测CSI患者特定的质量保证趋势,并且可以采用相同的值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/89d95955bd48/JMP-50-155-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/d8748373836d/JMP-50-155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/85a8be1e4329/JMP-50-155-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/ae9423a2f1c1/JMP-50-155-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/ae6457dd5290/JMP-50-155-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/89d95955bd48/JMP-50-155-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/d8748373836d/JMP-50-155-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/85a8be1e4329/JMP-50-155-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/ae9423a2f1c1/JMP-50-155-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/ae6457dd5290/JMP-50-155-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e32/12005663/89d95955bd48/JMP-50-155-g006.jpg

相似文献

1
Setting the Tolerance and Action Limit for Patient-specific Quality Assurance of Craniospinal Irradiation Volumetric Modulated Arc Therapy: Based on AAPM TG-218 Report.基于美国医学物理学家协会(AAPM)TG-218报告设定颅脊髓照射容积调强弧形治疗患者特异性质量保证的公差和行动限值
J Med Phys. 2025 Jan-Mar;50(1):155-159. doi: 10.4103/jmp.jmp_156_24. Epub 2025 Mar 7.
2
From 2D to 3D gamma passing rate tolerance and action limits for patient-specific quality assurance in volumetric-modulated arc therapy.容积调强弧形放疗中针对患者的质量保证的从二维到三维伽马通过率容差及行动限值
J Appl Clin Med Phys. 2025 Jun;26(6):e70025. doi: 10.1002/acm2.70025. Epub 2025 Feb 19.
3
Evaluating AAPM-TG-218 recommendations: Gamma index tolerance and action limits in IMRT and VMAT quality assurance using SunCHECK.评估 AAPM-TG-218 建议:使用 SunCHECK 对 IMRT 和 VMAT 质量保证进行 Gamma 指数容限和行动限评估。
J Appl Clin Med Phys. 2024 Jun;25(6):e14277. doi: 10.1002/acm2.14277. Epub 2024 Jan 19.
4
Implementation of TG-218 for patient-specific quality assurance tolerance and action limits determination: Gamma passing rate evaluation using 3DVH software.采用 3DVH 软件对 TG-218 进行特定患者质量保证容限和行动限确定的实施:伽马通过率评估。
Med Phys. 2022 Jul;49(7):4322-4334. doi: 10.1002/mp.15703. Epub 2022 May 23.
5
[Preliminary study on monitoring patient-specific volumetric modulated arc therapy quality assurance process with statistical process control methodology on the basis of TG-218 report].基于TG-218报告,运用统计过程控制方法监测个体化容积调强弧形放疗质量保证过程的初步研究
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2020 Oct 25;37(5):842-847. doi: 10.7507/1001-5515.202001016.
6
Incorporating plan complexity into the statistical process control of volumetric modulated arc therapy pre-treatment verifications.将计划复杂性纳入容积调强弧形治疗预处理验证的统计过程控制中。
Med Phys. 2024 Jun;51(6):3961-3971. doi: 10.1002/mp.17081. Epub 2024 Apr 17.
7
Development and Quality Assurance of Multileaf Collimator (MLC) Auto-Feathering Junctions for Multi-Isocenter Supine Volumetric Modulated Arc Therapy (VMAT) Craniospinal Axis Irradiation on Halcyon.用于在Halcyon设备上进行多等中心仰卧位容积调强弧形放疗(VMAT)全脑全脊髓照射的多叶准直器(MLC)自动羽化连接的开发与质量保证
Cureus. 2023 Sep 20;15(9):e45640. doi: 10.7759/cureus.45640. eCollection 2023 Sep.
8
Dosimetric comparison of short and full arc in spinal PTV in volumetric-modulated arc therapy-based craniospinal irradiation.基于容积调强弧形放疗的全脊髓照射中,短弧与全弧在脊髓计划靶体积中的剂量学比较。
Med Dosim. 2020;45(1):1-6. doi: 10.1016/j.meddos.2019.03.003. Epub 2019 Apr 15.
9
Modified volumetric modulated arc therapy technique with reduced planning and treatment time for craniospinal irradiation utilising two isocentres.采用双等中心的改良容积调强弧形治疗技术,可减少颅脊髓照射的计划和治疗时间。
J Med Radiat Sci. 2022 Sep;69(3):357-366. doi: 10.1002/jmrs.582. Epub 2022 Apr 22.
10
Evaluation of the conformity of intensity-modulated radiation therapy and volumetric modulated arc therapy using AAPM TG 119 protocol.使用 AAPM TG 119 协议评估调强放射治疗和容积旋转调强放射治疗的一致性。
Radiat Environ Biophys. 2024 Nov;63(4):557-571. doi: 10.1007/s00411-024-01091-2. Epub 2024 Aug 17.

本文引用的文献

1
Evaluating AAPM-TG-218 recommendations: Gamma index tolerance and action limits in IMRT and VMAT quality assurance using SunCHECK.评估 AAPM-TG-218 建议:使用 SunCHECK 对 IMRT 和 VMAT 质量保证进行 Gamma 指数容限和行动限评估。
J Appl Clin Med Phys. 2024 Jun;25(6):e14277. doi: 10.1002/acm2.14277. Epub 2024 Jan 19.
2
Assessment of using a gamma index analysis for patient-specific quality assurance in Japan.评估使用伽玛指数分析进行日本患者特异性质量保证。
J Appl Clin Med Phys. 2022 Oct;23(10):e13745. doi: 10.1002/acm2.13745. Epub 2022 Aug 26.
3
Evaluating suggested stricter gamma criteria for linac-based patient-specific delivery QA in the conventional and SBRT environments.
评估在常规和 SBRT 环境中基于直线加速器的患者特定交付 QA 中更严格的伽马标准建议。
Phys Med. 2022 Aug;100:72-80. doi: 10.1016/j.ejmp.2022.06.005. Epub 2022 Jun 24.
4
Implementation of TG-218 for patient-specific quality assurance tolerance and action limits determination: Gamma passing rate evaluation using 3DVH software.采用 3DVH 软件对 TG-218 进行特定患者质量保证容限和行动限确定的实施:伽马通过率评估。
Med Phys. 2022 Jul;49(7):4322-4334. doi: 10.1002/mp.15703. Epub 2022 May 23.
5
Radiotherapy in Medulloblastoma-Evolution of Treatment, Current Concepts and Future Perspectives.髓母细胞瘤的放射治疗——治疗的演变、当前概念与未来展望
Cancers (Basel). 2021 Nov 26;13(23):5945. doi: 10.3390/cancers13235945.
6
Analysis of clinical patient-specific pre-treatment quality assurance with the new helical tomotherapy platform, following the AAPM TG-218 report.根据 AAPM TG-218 报告,对新型螺旋断层放疗平台进行临床个体化治疗前质量保证的分析。
Radiat Oncol. 2021 Nov 22;16(1):226. doi: 10.1186/s13014-021-01952-w.
7
Applications of machine and deep learning to patient-specific IMRT/VMAT quality assurance.机器和深度学习在个体化调强放疗/容积旋转调强放疗质量保证中的应用。
J Appl Clin Med Phys. 2021 Sep;22(9):20-36. doi: 10.1002/acm2.13375. Epub 2021 Aug 3.
8
Analysis of patient-specific quality assurance for Elekta Unity adaptive plans using statistical process control methodology.使用统计过程控制方法对医科达Elekta Unity自适应计划进行患者特定质量保证分析。
J Appl Clin Med Phys. 2021 Apr;22(4):99-107. doi: 10.1002/acm2.13219. Epub 2021 Mar 23.
9
Application of TG-218 action limits to SRS and SBRT pre-treatment patient specific QA.将TG-218行动限值应用于立体定向放射治疗(SRS)和立体定向体部放射治疗(SBRT)治疗前患者特异性质量保证。
J Radiosurg SBRT. 2020;7(2):135-147.
10
Tolerance limits and methodologies for IMRT measurement-based verification QA: Recommendations of AAPM Task Group No. 218.调强放射治疗(IMRT)测量验证 QA 的容忍限度和方法:AAPM 工作组第 218 号报告的建议。
Med Phys. 2018 Apr;45(4):e53-e83. doi: 10.1002/mp.12810. Epub 2018 Mar 23.